Inspection prep notes · Data and records
Batch records and contemporaneous recording
Also called: batch record, batch production record, master production record
FDA looks less at whether batch records exist than at whether each step is recorded in full at the time it is performed and then reviewed. The findings below are quoted from warning letters and FDA 483s.
What inspectors cited
1Entries were not recorded and signed at the time the work was performed
Production tasks performed by operators were recorded later by the production supervisor, who was overseeing five production rooms at the same time.
FDA Warning Letter · Shree Jaya Laboratories PVT. LTD. · 2025-03-11 · View document
The chemist conducting the production stated that he "signs as the operator and that the checker will usually sign later because they trust each other."
FDA 483 · ChemPacific Corporation · 2026-10-23 · View document
2Batch records did not document each significant step
For example, your firm’s batch production records did not include each significant step in manufacturing, processing, and packaging of your drug products.
FDA Warning Letter · Sani-Care Salon Products, Inc. · 2024-06-25
Specifically, your firm's batch records do not include documentation and/or complete documentation of each significant step in the production of drug products.
FDA 483 · Mixlab TX LLC · 2024-09-19 · View document
3Records lacked necessary processing information and production instructions
Your batch record for (b)(4) lacked some of the critical processing information necessary to ensure consistent manufacturing and product quality. For example, you did not list (b)(4) and major equipment used in the manufacturing process.
FDA Warning Letter · Tianjin Kilo Pharmaceutical Sci-tech Co., Ltd. · 2026-08-18 · View document
The master batch production record lacks an established time limit and detailed production instructions to ensure the quality of intermediates and APIs are met for individual processing steps and/or total process.
FDA 483 · Qingdao Kangyuan Pharmaceutical Co., LTD · 2026-11-13 · View document
4Required records were not kept
Your firm indicated that you did not have production records, including batch records, for (b)(4) Nasal Spray batch (b)(4) .
FDA Warning Letter · Premier Nutra Pharma Inc. · 2023-05-09 · View document
Your firm does not maintain a master batch record.
FDA 483 · LCC Ltd. · 2026-10-20 · View document
5The quality unit did not properly review batch records
During the inspection, your regulatory consultant told FDA investigators that you both backdated review steps on batch production records for your OTC drug products.
FDA Warning Letter · Cosmobeauti Laboratories & Manufacturing Inc. · 2023-08-29 · View document
Your quality unit does not review production records adequately to ensure there are no errors that have occurred.
FDA 483 · Andelyn Biosciences, Inc. · 2026-10-30 · View document
Questions to check against your procedures
- Is work performed by operators ever recorded later by someone else?
- Does the checker sign the batch record at the time of verification?
- Does the batch record document each significant step in manufacturing, processing and packaging?
- Does the batch record list the critical processing information and the major equipment used?
- Is a master record maintained, and does it include time limits and detailed production instructions?
- Does the quality unit review batch records for errors, without backdating review steps?
Compiled by AI from public findings and checked by a person. Quotations are verbatim from the original documents; (b)(4) marks text redacted in the original. As of 2026-11-15.